Chuck Grassley

This is an institutional problem that is keeping the constitutional function of checks and balances from working.

I think that such behavior, whether you were personally involved or people underneath you were involved, is extremely disturbing.

The most transparent administration in the history of the country

Why should I support your confirmation if your office is consistently working behind the scenes to block me and my office from attending routine briefings and meetings?

Whether in Fast and Furious or in Mr. Kadzik's case, shooting letters willy nilly to Congress without checking on their accuracy is simply unacceptable.

Through consultation with the House Committee, I was able to obtain the handwritten notes of the staff who spoke with these attorneys at your firm.

The most stonewalling of any President

I, Senator Grassley, have been pushing for reforms for several years to enhance the Government's fraud enhancement capabilities relating to Federal health care funds.

I do not know anything controversial about this gentleman.

Today's hearing is the 14th judicial nomination hearing this year during which we will have considered a total of 48 judicial nominees.

In fact, for the entire year of 2005, the Judiciary Committee held only 6 hearings for 15 judicial and circuit nominees.

I welcome you as the nominees, and I know that you are proud of the advancement you have made in your profession.

Mr. Chairman, I thank you for holding this hearing, and I think it is very important that Congress do its oversight work.

The Government is spying on them and prying into their personal lives.

Thankfully, until the Boston bombing we had prevented large-scale terrorist attacks on American soil.

Consumers like competition, interoperability, and choice with respect to their devices.

Industry standards are critical to innovation and new technologies, products, and services.

We have seen an increase in lawsuits over the way that standard-essential patents are used and enforced.

According to the 2010 Federal Trade Commission report entitled 'Pay For Delay: How Drug Companies Payoffs Cost Consumers Billions,' these settlements cost consumers approximately $35 billion over 10 years.

I worked hard to make sure that this notice and filing provision was included in that legislation.

In my opinion, they only end up keeping drug costs artificially high for consumers and the taxpaying public.

This is a very important hearing that we're having to learn more about pay-for-delay agreements.

The reality is that these deals between brand-name and generic pharmaceutical companies delay the entry of generic medicines into the marketplace.

I think they harm drug competition.

We should be doing all we can to see that the American consumer has access to lower-priced drugs.